SLC6A8 and ovarian cancer: A panel of six genes: CCNE2, DKFZp1312, PPIC, EMP2, MAL2 and SLC6A8 may serve as potential markers for CTC derived from breast, endometrial, cervical, and ovarian cancers [41].